FDA.reportPublic FDA data

COPOVIDONE K25-31

Substance profile for UNII D9C330MD8B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for COPOVIDONE K25-31
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
D9C330MD8B
Preferred term
COPOVIDONE K25-31
Registry number
25086-89-9
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported
Chemical structure for COPOVIDONE K25-31
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

RxCUI
0
PubChem
0
NCIt
C80921
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
NCI ThesaurusC80921https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80921
FDA Substance Registration SystemD9C330MD8Bhttps://precision.fda.gov/uniisearch/srs/unii/D9C330MD8B

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PVP/VA COPOLYMERINACTIVE INGREDIENTD9C330MD8BBurberry Cashmere Long-Lasting Flawless Soft-Matte Foundation Sunscreen SPF20 Warm Nude No. 342
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BGABAPENTIN2
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BDRUG FACTS2
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BDiclofenac Sodium Extended-release Tablets8
PVP/VA COPOLYMERINACTIVE INGREDIENTD9C330MD8BGood Neighbor Pharmacy Itch Relief1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BCITALOPRAM HYDROBROMIDE3
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BBurberry Cashmere Long-Lasting Flawless Soft-Matte Foundation Sunscreen Broad Spectrum SPF 15 Mocha No.643
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BBurberry Cashmere Long-Lasting Flawless Soft-Matte Foundation Sunscreen Broad Spectrum SPF 20 Ochre No.202
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BDICLOFENAC SODIUM1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BTOC Kit finalCopy of Tox Kit 2(Importer)Tox Kit (Importer)refence productsThese highlights do not include all the information needed to use Toxicology Saliva Collection Kit safely and effectively.see full prescribing information for Toxicology Saliva Collection KitToxicology Saliva Collection Kit (Toxicology Saliva Collection Kit) KIT for ORAL use.Initial U.S. Approval:These highlights do not include all the information needed to use Toxicology Saliva Collection Kit safely and effectively.see full prescribi6
copovidoneINACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. Jentadueto ® (linagliptin and metformin hydrochloride) tablets Initial U.S. Approval: 20122
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BCitalopram Hydrobromide Tablets, USP1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use oxcarbazepine oral suspension, USP safely and effectively. See full prescribing information for oxcarbazepine oral suspension, USP. Oxcarbazepine oral suspension, USP for oral administration Initial U.S. Approval: 20008
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BBisoprolol Fumarate and Hydrochlorothiazide Tablets USP1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BDrug Facts2
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8Be6c92a3f-e194-4f28-bd8c-e1794cd6f4481
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BCitalopram Tablets, USP Rx Only5
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BDrug Facts1
PVP/VA COPOLYMERINACTIVE INGREDIENTD9C330MD8BDrug Facts1
PVP/VA COPOLYMERINACTIVE INGREDIENTD9C330MD8BDrug Facts2
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BProStat Bandage Spray2
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BFexofenadine HCl and Pseudoephedrine HCI ER Tablets USP 180240 mg1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BLidoPatch™3
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BBisoprolol Fumarate and Hydrochlorothiazide Tablets USP2
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BArthritis Therapy Homeopathic Fast Dissolving Tablets1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BGabapentin Tablets, USP 600 mg and 800 mg Allied Pharma Inc5
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BFERROUS SULFATE ENTERIC-COATED TABLETS3
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BDrug Facts1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BGabapentin Tablets USP2
PVP/VA COPOLYMERINACTIVE INGREDIENTD9C330MD8BYOUR LOGO HERE POISON IVY RELIEF1
copovidone K25-31INACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use FIBRICOR ® (fenofibric acid) Tablets safely and effectively. See full prescribing information for FIBRICOR. FIBRICOR ® (fenofibric acid) Tablets, for oral use Initial U.S. Approval: 199313
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BAxe AntiDandruff Styling Cream1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8B7d8c8762-e491-4798-8866-0db6425308e82
Copovidone K25-31INACTIVE INGREDIENTD9C330MD8BCitalopram Tablets USP1
Copovidone K25-31INACTIVE INGREDIENTD9C330MD8BCitalopram Tablets USP1
Copovidone K25-31INACTIVE INGREDIENTD9C330MD8BCitalopram Tablets USP1
PVP/VA COPOLYMERINACTIVE INGREDIENTD9C330MD8B2a00e54c-b302-42eb-a192-a2af5f420a4b1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BFERROUS SULFATE ENTERIC-COATED TABLETS2
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BChronic Fatigue Therapy™ Homeopathic Fast Dissolving Tablets1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BGabapentin Tablets, USP3
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BALLEGRA-D ® 24 HOUR (fexofenadine HCl 180 mg and pseudoephedrine HCl 240 mg) Extended-Release Tablets2
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BDrug Facts1
copovidoneINACTIVE INGREDIENTD9C330MD8BEstradiol/Norethindrone Acetate Tablets1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BBuPROPion hydrochloride extended-release tablets, USP (SR)1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8B9f5a14c2-b460-402e-acb4-04402278e64b2
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8B531112e5-db64-457d-af7d-baa86f2bcec22
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BGabapentin Tablets USP3
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20002
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BCitalopram Tablets, USP5
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use CASODEX® safely and effectively. See full prescribing information for CASODEX. CASODEX® (bicalutamide) Tablet for Oral use Initial U.S. Approval: 19952
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BCitalopram Tablets USP1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BGabapentin Tablets USP4
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BGLYBURIDE and METFORMIN HYDROCHLORIDE TABLETS USP Rx only1
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BCitalopram Tablets, USP1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8B33694be4-87ce-4d25-92f6-6ae517bdf5ff1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BBuPROPion hydrochloride extended-release tablets, USP (SR)1
copovidoneINACTIVE INGREDIENTD9C330MD8BFENTANYL TRANSDERMAL SYSTEM CII1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules, 0.4 mg Initial U.S. Approval: 19973
Copovidone K25-31INACTIVE INGREDIENTD9C330MD8BCVS ® pharmacy COLD REMEDY PLUS FAST MELTING1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BCitalopram Tablets, USP1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BSentralopram AM-109
COPOVIDONEINACTIVE INGREDIENTD9C330MD8B56bf1b0a-463a-4324-957b-585d4cf352ee1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BGLYBURIDE and METFORMIN HYDROCHLORIDE TABLETS USP Rx only 5710 5711 57121
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BHydrocone Bitartrate and Acetaminophen1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
copovidoneINACTIVE INGREDIENTD9C330MD8BThese highlights do not include all the information needed to use ROZEREM safely and effectively. See full prescribing information for ROZEREM. ROZEREM (ramelteon) tablet, film coated for oral use Initial U.S. Approval: 20051
COPOVIDONEINACTIVE INGREDIENTD9C330MD8Bdrug facts2
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BDrug Facts CVS Congestion Relief DM1
CopovidoneINACTIVE INGREDIENTD9C330MD8BRITE AID ® PHARMACY1
CopovidoneINACTIVE INGREDIENTD9C330MD8BRITE AID ® PHARMACY1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8B2f45060b-ce5c-4869-87c0-fd7d2224e86c2
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BIbuprofen Tablets, USP1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8B5ac5271e-316c-4802-a172-aa602d22571f1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8B9fb17714-bdb1-4bfa-bc04-d9c011604cde1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8Bf738ddad-fef0-43cb-b791-b046fdcec3111
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BCitalopram Tablets, USP1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BCitalopram Tablets, USP1
COPOVIDONEINACTIVE INGREDIENTD9C330MD8B5caff592-a90f-420d-a6ec-9b2dc914529e2
COPOVIDONEINACTIVE INGREDIENTD9C330MD8B7a51d289-2013-4d37-adf2-91ea49df79321
COPOVIDONEINACTIVE INGREDIENTD9C330MD8B741e8b74-2bb5-4153-9727-92ad91e9e9a01
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BCitalopram Tablets, USP2
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BIbuprofen Tablets, USP2
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BCITALOPRAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3973
copovidoneINACTIVE INGREDIENTD9C330MD8BCELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC ]3225
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BROZEREM TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3168
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BGABAPENTIN TABLET [LAKE ERIE MEDICA & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3163
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BNORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.]1509
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BFENTANYL PATCH [BRYANT RANCH PREPACK]1000
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BGLYBURIDE AND METFORMIN TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BGLYBURIDE AND METFORMIN TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BGLYBURIDE AND METFORMIN TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BGRALISE (GABAPENTIN) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BVIEKIRA PAK (DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]203
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BCITALOPRAM HYDROBROMIDE TABLET, FILM COATED [REMEDYREPACK INC. ]148
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BMETFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) TABLET [REMEDYREPACK INC. ]58
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BCARVEDILOL TABLET [REMEDYREPACK INC. ]56
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BTECHNIVIE (OMBITASVIR AND PARITAPREVIR AND RITONAVIR) KIT [ABBVIE INC.]53
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BETODOLAC (ETODOLAC) TABLET [REMEDYREPACK INC. ]39
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BCITALOPRAM TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.]31
copovidoneINACTIVE INGREDIENTD9C330MD8BJENTADUETO (LINAGLIPTIN) TABLET, FILM COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]28
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BNEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]27
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BHYDROCODONE BITARTRATE AND ACETAMINOPHEN (HYDROCODONE BITARTRATE AND ACETAMINOPHEN) TABLET [REMEDYREPACK INC. ]20
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BGLYBURIDE AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]19
copovidoneINACTIVE INGREDIENTD9C330MD8BCELEXA (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [FOREST LABORATORIES, INC.]18
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BIBUPROFEN TABLET, FILM COATED [MAJOR PHARMACEUTICALS]16
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BCITALOPRAM HYDROBROMIDE TABLET [CARDINAL HEALTH]15
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BALLEGRA-D 24 HOUR ALLERGY AND CONGESTION (FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [CHATTEM, INC.]14
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BCASODEX (BICALUTAMIDE) TABLET [ASTRAZENECA PHARMACEUTICALS LP]13
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BCITALOPRAM (CITALOPRAM HYDROBROMIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]13
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BCITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [PD-RX PHARMACEUTICALS, INC.]13
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BCITALOPRAM HYDROBROMIDE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.]13
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BBUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [SANDOZ INC]12
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BGABAPENTIN TABLET [GLENMARK PHARMACEUTICALS INC., USA]12
COPOVIDONEINACTIVE INGREDIENTD9C330MD8BGLYBURIDE AND METFORMIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]12
COPOVIDONE K25-31INACTIVE INGREDIENTD9C330MD8BLEVETIRACETAM TABLET, FILM COATED [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]12